These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34881283)

  • 1. Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity.
    Xin X; Cheng C; Bei-Yu C; Hong-Shan L; Hua-Jie T; Xin W; Zi-Ming A; Qin-Mei S; Yi-Yang H; Qin F
    Front Nutr; 2021; 8():784354. PubMed ID: 34881283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis.
    Xin X; Cai BY; Chen C; Tian HJ; Wang X; Hu YY; Feng Q
    Nutr Metab (Lond); 2020; 17():40. PubMed ID: 32508961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression.
    Huang X; Chen W; Yan C; Yang R; Chen Q; Xu H; Huang Y
    Biomed Pharmacother; 2019 Oct; 118():109258. PubMed ID: 31545283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model.
    Li H; Wang Q; Chen P; Zhou C; Zhang X; Chen L
    Front Pharmacol; 2021; 12():788558. PubMed ID: 34938193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
    World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged-release pirfenidone prevents obesity-induced cardiac steatosis and fibrosis in a mouse NASH model.
    Gutiérrez-Cuevas J; Sandoval-Rodríguez A; Monroy-Ramírez HC; Vazquez-Del Mercado M; Santos-García A; Armendáriz-Borunda J
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):927-938. PubMed ID: 32621046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver].
    Suzuki S; Sato Y; Umegaki K; Chiba T
    Yakugaku Zasshi; 2016; 136(9):1297-305. PubMed ID: 27592832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.
    Dey P; Olmstead BD; Sasaki GY; Vodovotz Y; Yu Z; Bruno RS
    J Nutr Biochem; 2020 Oct; 84():108455. PubMed ID: 32688217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
    J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
    Kohli R; Kirby M; Xanthakos SA; Softic S; Feldstein AE; Saxena V; Tang PH; Miles L; Miles MV; Balistreri WF; Woods SC; Seeley RJ
    Hepatology; 2010 Sep; 52(3):934-44. PubMed ID: 20607689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon tetrachloride (CCl
    Zhang G; Wang X; Chung TY; Ye W; Hodge L; Zhang L; Chng K; Xiao YF; Wang YJ
    BMC Gastroenterol; 2020 Oct; 20(1):339. PubMed ID: 33059584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine ameliorates non-alcoholic steatohepatitis in ApoE
    Yang J; Ma XJ; Li L; Wang L; Chen YG; Liu J; Luo Y; Zhuang ZJ; Yang WJ; Zang SF; Shi JP
    Exp Ther Med; 2017 Nov; 14(5):4134-4140. PubMed ID: 29075339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.
    Ibrahim SH; Gores GJ; Hirsova P; Kirby M; Miles L; Jaeschke A; Kohli R
    Liver Int; 2014 Mar; 34(3):427-37. PubMed ID: 24256559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a diet-induced Macaca fascicularis model of non-alcoholic steatohepatitis with dietary and pioglitazone interventions.
    Camacho RC; Polidori D; Chen T; Chen B; Hsu HH; Gao B; Marella M; Lubomirski M; Beavers T; Cabrera J; Wong P; Nawrocki AR
    Diabetes Obes Metab; 2023 Apr; 25(4):1068-1079. PubMed ID: 36546607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin Gallate Protects Mice against Methionine-Choline-Deficient-Diet-Induced Nonalcoholic Steatohepatitis by Improving Gut Microbiota To Attenuate Hepatic Injury and Regulate Metabolism.
    Ning K; Lu K; Chen Q; Guo Z; Du X; Riaz F; Feng L; Fu Y; Yin C; Zhang F; Wu L; Li D
    ACS Omega; 2020 Aug; 5(33):20800-20809. PubMed ID: 32875214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.